* Q4 earnings match Jan. 11 profit warning
* Sees weak western European demand
(Adds detail, background, shares)
STOCKHOLM Jan 25 Swedish medical equipment
group Getinge, which has been feeling the bite from
public sector cutbacks in Europe, expects strong demand in
emerging markets to drive growth this year.
The maker of surgical theatre equipment, such as heart-lung
support and anaesthesia systems, posted fourth-quarter earnings
in line with its warning on Jan. 11 that weaker demand in
western Europe had hit invoicing and orders.
Getinge forecast favourable profit growth in 2013, excluding
restructuring costs, despite a new medical device tax in the
United States and the adverse effect of exchange rates.
"Demand in the markets outside North America and western
Europe, which comprise an increasing share of group sales, is
expected to continue to show strong growth in terms of
medical-technical capital goods, such as disposables and
services," it said.
Order intake fell 1 percent in the fourth quarter, for the
first time in two years, as demand for medical-technical capital
goods fell in heavily indebted western European economies, and
Getinge predicted that demand in the region for such products
would stay weak this year.
Operating profit before interest, amortisation and
restructuring costs edged up 1 percent year on year, to 1.94
billion crowns ($299 million).
It unexpectedly raised its dividend for 2012, to 4.15 crowns
from 3.75 crowns. The company's shares, which had dived on the
profit warning, were up 1.7 percent at 1200 GMT.
($1 = 6.4966 Swedish crowns)
(Reporting by Anna Ringstrom; Editing by David Goodman)